Catalyst Capital Advisors LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 67 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 29.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Catalyst Capital Advisors LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$748,000
-18.3%
305,0000.0%0.11%
-12.2%
Q3 2015$915,000
-83.1%
305,000
-76.7%
0.12%
-80.5%
Q2 2015$5,411,000
+16.2%
1,310,000
+21.9%
0.63%
+18.2%
Q1 2015$4,655,000
+64.1%
1,075,000
+12.6%
0.53%
+60.4%
Q4 2014$2,836,000
-10.6%
955,0000.0%0.33%
-18.6%
Q3 2014$3,171,000
+51.0%
955,000
+15.1%
0.41%
+19.2%
Q2 2014$2,100,000830,0000.34%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders